EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 180 filers reported holding EAGLE PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 2.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,888,904 | +9.4% | 1,134,363 | +34.9% | 0.35% | +6.1% |
| Q2 2023 | $16,350,731 | +5.7% | 841,087 | +54.3% | 0.33% | +0.3% |
| Q1 2023 | $15,463,069 | +27.1% | 545,050 | +31.0% | 0.33% | -3.8% |
| Q4 2022 | $12,164,854 | -1.6% | 416,177 | -11.0% | 0.34% | +5.6% |
| Q3 2022 | $12,361,000 | -40.1% | 467,857 | +0.8% | 0.32% | -35.9% |
| Q2 2022 | $20,628,000 | -3.5% | 464,292 | +7.5% | 0.50% | +10.0% |
| Q1 2022 | $21,372,000 | -31.7% | 431,850 | -29.7% | 0.46% | -32.9% |
| Q4 2021 | $31,283,000 | -16.7% | 614,365 | -8.7% | 0.68% | -16.2% |
| Q3 2021 | $37,544,000 | +22.4% | 673,076 | -6.1% | 0.82% | +19.5% |
| Q2 2021 | $30,682,000 | +52.6% | 716,873 | +46.4% | 0.68% | +43.3% |
| Q1 2021 | $20,104,000 | +63.5% | 489,627 | +85.2% | 0.48% | +50.2% |
| Q4 2020 | $12,295,000 | +86.8% | 264,397 | +70.7% | 0.32% | +39.6% |
| Q3 2020 | $6,582,000 | +1835.9% | 154,924 | +2084.8% | 0.23% | +2170.0% |
| Q2 2020 | $340,000 | -95.1% | 7,091 | -95.3% | 0.01% | -95.9% |
| Q1 2020 | $6,928,000 | +2120.5% | 150,601 | +2802.9% | 0.24% | +3357.1% |
| Q4 2019 | $312,000 | +7.6% | 5,188 | +1.1% | 0.01% | 0.0% |
| Q3 2019 | $290,000 | -29.6% | 5,131 | -30.6% | 0.01% | -22.2% |
| Q2 2019 | $412,000 | -62.9% | 7,393 | -66.4% | 0.01% | -65.4% |
| Q1 2019 | $1,110,000 | +29.4% | 21,978 | +3.1% | 0.03% | +18.2% |
| Q4 2018 | $858,000 | +237.8% | 21,310 | +482.6% | 0.02% | +266.7% |
| Q3 2018 | $254,000 | -72.0% | 3,658 | -69.5% | 0.01% | -70.0% |
| Q2 2018 | $907,000 | -31.7% | 11,985 | -52.5% | 0.02% | -28.6% |
| Q1 2018 | $1,328,000 | – | 25,219 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ProQuest Associates IV LLC | 3,652,284 | $302,920,000 | 91.10% |
| Hudson Executive Capital LP | 1,901,200 | $157,686,000 | 21.62% |
| JW Asset Management, LLC | 525,755 | $43,606,000 | 9.08% |
| Cormorant Asset Management, LP | 200,000 | $16,588,000 | 2.41% |
| Park West Asset Management LLC | 488,128 | $40,485,000 | 2.36% |
| Opaleye Management Inc. | 50,000 | $4,147,000 | 2.06% |
| Ranger Investment Management | 283,954 | $23,551,000 | 1.71% |
| Pier Capital, LLC | 74,732 | $6,198,000 | 1.06% |
| Bellevue Group AG | 67,700 | $5,615,000 | 0.75% |
| Orbimed Advisors | 671,000 | $55,653,000 | 0.63% |